Bo Yang | Cardiovascular Disease | Best Researcher Award 2025

Published on 04/09/202504/09/2025 by Cardiology and Cardiovascular Medicine

Prof. Bo Yang | Cardiovascular Disease | Best Researcher Award

Wenzhou Medical University | China

Author Profile

Early Academic Pursuits

Dr. Bo Yang began his academic journey with a strong foundation in the field of nutrition and health sciences. He pursued his doctoral degree at Zhejiang University through a collaborative international research program with Harvard University. This early exposure to global academic environments enabled him to acquire a multidisciplinary perspective and laid the groundwork for his career in nutritional science and lipid medicine. His academic training emphasized both molecular-level investigation and broader public health perspectives, bridging basic research with applied health outcomes.

Professional Endeavors

Following his doctoral studies, Dr. Yang expanded his expertise through postdoctoral training at China Medical University in Taiwan. These experiences enriched his understanding of advanced methodologies in nutrition and health research. He later joined Wenzhou Medical University, where he currently serves as a Research Professor and Director of the Institute of Lipids Medicine. In this leadership role, Dr. Yang oversees both research and academic development, guiding projects that integrate basic, clinical, and translational research approaches.

Contributions And Research Focus

Dr. Yang’s research centers on nutritional epidemiology, functional lipids, and health management. His work explores the role of lipid metabolism and bioactive compounds in mind-body health, with a special emphasis on how dietary interventions influence chronic disease prevention. By integrating molecular nutrition with population-based approaches, his research addresses pressing public health challenges while providing evidence for precision nutrition strategies. His expertise spans functional lipids, mind-body health, and diet-related interventions, making significant contributions to the field of nutritional sciences.

Impact And Influence

With an extensive body of published work in peer-reviewed scientific journals, Dr. Yang has established himself as a recognized voice in the field of nutrition and lipid research. His contributions include more than fifty publications in SCI-indexed journals. Beyond his own research, he actively serves as a peer reviewer for prestigious journals such as Brain, Behavior & Immunity, Food & Function, and Nutrients. His editorial role as Statistical Editor for the British Journal of Nutrition further demonstrates his influence in shaping scientific communication and ensuring methodological rigor in nutrition science.

Academic Cites

Dr. Yang’s publications have been widely cited by scholars and researchers across the globe. His contributions to nutritional epidemiology and lipid metabolism have provided reference points for emerging research in functional foods, mind-body health, and chronic disease prevention. By bridging laboratory findings with population-based studies, his work is frequently referenced in both clinical nutrition and public health research, enhancing the academic discourse in these fields.

Legacy And Future Contributions

Dr. Yang’s legacy lies in his integration of molecular nutrition with population-based health studies, offering a holistic approach to understanding the role of diet in human health. His leadership at the Institute of Lipids Medicine positions him to continue fostering innovation in nutritional research and health management. Future contributions are expected to expand into precision nutrition, functional food development, and preventive strategies for chronic diseases, influencing both academic research and public health policy.

Conclusion

Dr. Bo Yang exemplifies the qualities of an accomplished researcher and academic leader in nutritional science and lipid medicine. His career demonstrates a commitment to advancing scientific knowledge, mentoring future scholars, and addressing global health challenges through nutrition-focused solutions. With his proven track record of impactful research, editorial leadership, and international collaboration, Dr. Yang is poised to make enduring contributions to the fields of nutrition, health, and medicine.

Notable Publications

"Effect of Clostridium butyricum against Microglia‐Mediated Neuroinflammation in Alzheimer's Disease via Regulating Gut Microbiota and Metabolites Butyrate"

Authors: Jing Sun, Jingxuan Xu, Bo Yang, Keyang Chen, Yu Kong, Na Fang, Tianyu Gong, Fangyan Wang, Zongxin Ling, Jiaming Liu
Journal: Molecular nutrition & food research
Year: 2020

"Effects of low-fat compared with high-fat diet on cardiometabolic indicators in people with overweight and obesity without overt metabolic disturbance: a systematic review and meta-analysis of randomised controlled trials"

Authors: Mengqing Lu, Yi Wan, Bo Yang, Catherine E Huggins, Duo Li
Journal: British Journal of Nutrition
Year: 2018

"Effects of vegetarian diets on blood lipids: a systematic review and meta‐analysis of randomized controlled trials"

Authors: Fenglei Wang, Jusheng Zheng, Bo Yang, Jiajing Jiang, Yuanqing Fu, Duo Li
Journal: Journal of the American Heart Association
Year: 2015

"Ratio of n-3/n-6 PUFAs and risk of breast cancer: a meta-analysis of 274135 adult females from 11 independent prospective studies"

Authors: Bo Yang, Xiao-Li Ren, Yuan-Qin Fu, Jin-Long Gao, Duo Li
Journal: BMC cancer
Year: 2014

Dani Qin | Cardiovascular Disease | Best Researcher Award

Published on 18/08/202518/08/2025 by Cardiology and Cardiovascular Medicine

Dr. Dani Qin | Cardiovascular Disease | Best Researcher Award

Yixing People's Hospital | China

Author Profiles

Scopus

Orcid

Early Academic Pursuits

Qin Dani began her academic journey with a strong foundation in pediatrics, completing her studies at a prestigious medical university and further pursuing advanced training. Her dedication to continuous learning is evident as she continues doctoral studies at a reputed university. Her academic background laid the groundwork for her clinical expertise and research orientation in pediatric healthcare.

Professional Endeavors

She has established herself as a key figure in the Department of Pediatrics at Yixing People's Hospital, where she has been contributing her expertise for many years. During her career, she also pursued advanced studies and training at well-regarded medical institutions, which broadened her clinical skills and enriched her professional development. She currently holds a leadership role as an Associate Chief Physician and plays an active part in pediatric development teams, shaping the direction of child healthcare services.

Contributions and Research Focus

Her clinical work spans the diagnosis and treatment of a wide spectrum of pediatric conditions, with particular strengths in infant and toddler health care, respiratory disorders, digestive system diseases, and neonatal health management. She has led several important research projects at provincial and municipal levels, demonstrating her commitment to bridging clinical practice with academic research. Her published works reflect a dedication to advancing pediatric medicine through evidence-based studies and practical insights.

Impact and Influence

Through her leadership and expertise, she has significantly contributed to improving pediatric care standards in her community and beyond. Her ability to manage both common and critical pediatric illnesses has earned her recognition among colleagues and institutions alike. Her influence extends to mentoring young professionals, thereby fostering the next generation of pediatric specialists.

Academic Cites

She has authored numerous academic publications in both international and national journals, with multiple contributions recognized in core and indexed platforms. Her scholarly work has been acknowledged through prestigious awards in natural science and academic excellence, showcasing her impact in both scientific and clinical communities.

Legacy and Future Contribution

Her career trajectory reflects a deep commitment to pediatric medicine, both in clinical practice and academic advancement. With her ongoing doctoral research, she is expected to make further strides in pediatric healthcare innovations. Her legacy will likely continue through her contributions to research, her role in nurturing young professionals, and her influence on public health standards in pediatrics.

Recognition and Honors

She has received several commendations from healthcare authorities and academic institutions for her outstanding contributions, including recognition for advanced individual achievements and excellence in academic publications. These accolades highlight her dedication, professionalism, and long-term impact in the medical field.

Conclusion

Qin Dani exemplifies the qualities of an accomplished physician, researcher, and academic leader. Her blend of clinical expertise, research achievements, and commitment to advancing pediatric medicine has left a lasting mark on both medical practice and scientific scholarship. With a proven record of excellence and continued pursuit of innovation, she stands as a role model in the field of pediatrics, poised to make even greater contributions in the years ahead.

Notable Publications

"Methionine sulfoxide suppresses adipogenic differentiation by regulating the mitogen‐activated protein kinase signaling pathway"

Authors: Dani Qin; Yong Lei; Wen Xie; Qiuju Zheng; Zhou Peng; Yiwen Liu; Biao Dai; Tieliang Ma; Ping
Journal: Cell Biology
Year: 2023

"Effects of miR-19b Overexpression on Proliferation, Differentiation, Apoptosis and Wnt/β-Catenin Signaling Pathway in P19 Cell Model of Cardiac Differentiation In Vitro"

Authors: Da-Ni Qin; Lingmei Qian; De-Liang Hu; Zhang-Bin Yu; Shu-Ping Han; Chun Zhu; Xuejie Wang;
Journal: Cell Biochemistry and Biophysics
Year: 2013

Yongsub Choi | Cardiovascular Disease | Best Researcher Award

Published on 20/03/202520/03/2025 by Cardiology and Cardiovascular Medicine

Dr. Yongsub Choi | Cardiovascular Disease | Best Researcher Award

Dr. Yongsub Choi, Bellin Memorial Hospital, South Korea

Dr. Yongsub Choi is a dedicated internal medicine physician at Bellin Memorial Hospital, Green Bay, WI. He completed his MBBS (Summa Cum Laude) from Harbin Medical University, China, and an Internal Medicine Residency at BronxCare Health System, NYC. With extensive research experience in cardiology, nephrology, and gastroenterology, he has contributed to advancements in ventricular arrhythmia, atrial fibrillation, and liver recovery. Dr. Choi’s diverse background includes leadership roles, international medical practice, and teaching. His commitment to patient care, research, and global healthcare improvement makes him a distinguished figure in the field of internal medicine.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

🎓EARLY ACADEMIC PURSUITS:

Dr. Yongsub Choi’s academic journey is marked by excellence and dedication. He earned his Bachelor of Medicine, Bachelor of Surgery (MBBS) from Harbin Medical University, China, graduating Summa Cum Laude. His academic excellence was evident throughout his studies, securing the First Prize Scholarship multiple times (2008-2009, 2011-2014). Prior to his medical education, he pursued Theology and Anthropology at Don Bosco Center of Studies, Manila, Philippines, where he graduated Cum Laude. Additionally, he completed his Bachelor of Philosophy (B.Ph) at Gwangju Catholic University, South Korea.

🏥PROFESSIONAL ENDEAVORS:

Dr. Choi has built a dynamic and diverse career in internal medicine, research, and leadership. Currently, he serves as a Hospitalist at the Department of Internal Medicine, Apogee Physicians, Bellin Memorial Hospital, Green Bay, WI (April 2023 – Present). His previous medical roles include:

Resident Physician at BronxCare Health System, NYC, USA (Feb 2020 – Jan 2023)
Locum Intern at Savanna-La-Mar Public General Hospital, Jamaica (Jan – June 2019)

In addition to his medical career, he held leadership roles such as:

Acting Executive Director (Apr 2007 – Feb 2008) at International Cooperational Technical High School, Yanji, China
English Teacher at Baosigao Technical High School, Taiwan
Assistant Parish Priest at Gurosamdong Parish, South Korea
Private Soldier in the Republic of Korea Army, Cheolwon, South Korea

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR DISEASE:

Dr. Choi’s contributions to medical research have significantly impacted the fields of cardiology, nephrology, and gastroenterology. His research roles include:

Research Assistant – First Affiliated Hospital of Harbin Medical University, China

Investigated modulation of activated astrocytes in the hypothalamus paraventricular nucleus to prevent ventricular arrhythmia during acute myocardial infarction (July 2019 – Jan 2020).
Explored sonodynamic therapy for atrial fibrillation (AF) using a rabbit model (Mar 2017 – June 2018).
Studied mesenchymal stem cells with enhanced Bcl-2 expression to improve liver recovery in hepatic cirrhosis (July 2014 – Feb 2017).

Research Scholar – Albert Einstein College of Medicine, Bronx, NY

Focused on nephrology-related research under Dr. Victor L. Schuster, M.D. (June 2018 – Dec 2018).

🌍IMPACT AND INFLUENCE:

Dr. Choi’s work bridges clinical practice, academia, and international healthcare initiatives. His contributions extend beyond medical practice to mentorship, leadership, and medical education. His experience in multiple countries (USA, China, Jamaica, Taiwan, South Korea, and the Philippines) highlights his global perspective on healthcare and medical research.

🏅ACADEMIC CITES AND HONORS:

Dr. Choi has received numerous awards and recognitions:
Graduated Summa Cum Laude – Harbin Medical University (2014)
First Prize Scholarship (Top Student) – Harbin Medical University (2008-09, 2011-14)
Secretary of Class of 2008 – Harbin Medical University (2012-2014)
Cum Laude – Don Bosco Center of Studies, Manila, Philippines (2001)

🚀LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Choi continues to shape the future of internal medicine and medical research. His extensive experience in cardiology, nephrology, and gastroenterology positions him as a key contributor to advancements in patient care and treatment methodologies. Moving forward, he aims to:

Enhance clinical excellence through evidence-based medicine.
Contribute to medical education and mentorship.
Advance research in cardiovascular and metabolic diseases.
Improve healthcare accessibility and quality in underprivileged regions.

🌟CONCLUSION:

Dr. Yongsub Choi’s journey is a testament to dedication, excellence, and global impact in internal medicine and research. His expertise in cardiology, nephrology, and gastroenterology has contributed to significant advancements in patient care. With a strong foundation in clinical practice, leadership, and education, he continues to inspire future medical professionals. His commitment to evidence-based medicine, mentorship, and international healthcare development reflects his passion for improving lives worldwide. As he moves forward, Dr. Choi remains a trailblazer in internal medicine, striving for innovation and excellence in patient care and medical research.

TOP NOTABLE PUBLICATION

Probability assessment of pulmonary embolism using clinical and laboratory variables in hospitalized patients: A single-center, retrospective observational study

Authors: Y. Choi, Yongsub; N. Prasai, Neeti; T. Bhatt, Tanushree; A. Latif, Amber; M. Khaja, Misbahuddin

Journal: Thrombosis Update

Year: 2024

Litao Guo | Cardiac Rehabilitation | Best Researcher Award

Published on 17/02/202517/02/2025 by Cardiology and Cardiovascular Medicine

Prof. Litao Guo | Cardiac Rehabilitation | Best Researcher Award

Prof. Litao Guo, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

Prof. Litao Guo is a Deputy Director and Associate Chief Physician at The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China. With over 18 years of experience in intensive care medicine, he specializes in cardiopulmonary resuscitation (CPR), ECMO therapy, and critical patient management. Prof. Guo is also an expert in intelligent simulation teaching for emergency skills training. His research includes advanced ECMO treatments and innovative CPR training methods using intelligent simulation platforms. He has published 16 research papers, contributing significantly to critical care medicine and improving patient outcomes in high-risk medical situations.

AUTHOR PROFILE

Scopus Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Litao Guo embarked on his academic journey in intensive care medicine, where he spent more than 18 years developing his expertise. From a resident to an associate chief physician, he gained valuable experience and hands-on knowledge in managing critically ill patients. Prof. Guo has also served as a master tutor, fostering the next generation of healthcare professionals, particularly in cardiopulmonary resuscitation (CPR) and ECMO treatment. This foundation in intensive care provided him with a deep understanding of patient management and critical interventions.

💼PROFESSIONAL ENDEAVORS:

Currently, Prof. Guo serves as the Deputy Director and Associate Chief Physician at The First Affiliated Hospital of Xi’an Jiaotong University in Xi’an, China. His daily responsibilities include overseeing the treatment and management of critically ill patients, particularly those requiring advanced life-saving procedures such as ECMO and CPR. He plays a pivotal role in shaping clinical practices, guiding patient care, and contributing to the advancement of intensive care medicine. His leadership is integral to the hospital’s focus on improving patient outcomes in high-stakes medical situations.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIAC REHABILITATION:

Prof. Guo is widely recognized for his research on intelligent simulation teaching and training methods, particularly in CPR. His work involves leveraging cutting-edge technology to enhance the teaching and practical skills of medical staff in emergency procedures. He has been instrumental in developing an intelligent simulation platform to train teams in effective CPR techniques, emphasizing team coordination, division of labor, and the standing position during resuscitation efforts. Additionally, his research delves into the management of ECMO therapy, focusing on treating complications such as massive airway bleeding with early clamping and advanced intervention measures.

🌍IMPACT AND INFLUENCE:

Prof. Guo’s research and clinical contributions have had a significant impact on improving outcomes for critically ill patients. His work on ECMO combined with advanced airway management has been especially groundbreaking, offering new insights and techniques to reduce mortality rates. His intelligent simulation teaching platform is transforming the way first responders and healthcare professionals are trained, ensuring they are equipped with the best skills to save lives. Prof. Guo’s publications, including 16 relevant research papers, have gained widespread recognition within the medical community.

📚ACADEMIC CITATIONS:

Prof. Guo has published 16 research papers, many of which focus on innovative approaches to CPR and ECMO. His scholarly work has contributed to the growing body of knowledge in intensive care medicine, particularly in areas that directly affect patient survival in critical care settings. These publications are frequently cited by other researchers, underscoring the importance of his work in advancing medical practice.

🔮LEGACY AND FUTURE CONTRIBUTIONS:

Prof. Guo is dedicated to further advancing intensive care medicine through both his clinical practice and research endeavors. His focus on innovative training techniques and treatment protocols, such as ECMO and CPR management, ensures that future healthcare providers will be well-equipped to manage complex and life-threatening situations. His legacy will be one of continuous improvement in the fields of sepsis, resuscitation, and critical care, with lasting effects on the healthcare system and patient care outcomes.

🌟CONCLUSION:

Prof. Litao Guo’s work in intensive care medicine, particularly in cardiopulmonary resuscitation (CPR) and ECMO therapy, has had a profound impact on improving patient care and outcomes in critical settings. His pioneering research on intelligent simulation platforms for emergency training is revolutionizing medical education, ensuring better preparedness among healthcare teams. With over 18 years of experience and 16 published papers, his contributions continue to shape the field. Prof. Guo’s commitment to advancing both clinical practice and medical education ensures that his legacy will inspire future generations of healthcare professionals.

TOP NOTABLE PUBLICATIONS

Exploration of cardiopulmonary resuscitation teamwork training for maternal cardiac arrest using the SimMan intelligent simulation platform: A simulation teaching study

Authors: Zhang, Ruirui; Liu, Yu; Zhang, Mingming; Bai, Hongliang; Guo, Litao

Journal: Health Science Reports

Year: 2024

Regional Practice Variation and Outcomes in the Standard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) Trial: A Post Hoc Secondary Analysis

Authors: Vaara, Suvi T.; Neto, Ary Serpa; Bellomo, Rinaldo; Yang, Yang; Padayachee, Laven

Journal: Critical Care Explorations

Year: 2024

Yuan-Biao Qiao | Cardiovascular Pharmacology | Best Researcher Award

Published on 23/01/202523/01/2025 by Cardiology and Cardiovascular Medicine

Prof. Yuan-Biao Qiao | Cardiovascular Pharmacology | Best Researcher Award

Prof. Yuan-Biao Qiao, Shanxi University of Chinese Medicine, China

Prof. Yuan-Biao Qiao is a senior leader at the Shanxi Key Laboratory of Innovative Drug for the Treatment of Serious Diseases Basing on Chronic Inflammation, Shanxi University of Chinese Medicine, China. He holds a BC degree from Taiyuan University of Science and Technology (1992), an MS from Wuhan University (2005), and a Ph.D. from Qingdao University of Science and Technology (2007). Prof. Qiao completed post-doctoral research at Zhejiang University (2008–2010). With over 20 published research articles and a Shanxi Scientific and Technical Award, his work focuses on innovative drug development and integrating traditional Chinese medicine with modern science.

Author Profile

Scopus Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Yuan-Biao Qiao’s academic journey began with his BC degree from Taiyuan University of Science and Technology in 1992. He furthered his studies at Wuhan University, earning an MS degree in 2005, followed by a Ph.D. from Qingdao University of Science and Technology in 2007. These foundational years highlight his dedication to acquiring a robust academic foundation, enabling him to excel in the field of medicine and traditional Chinese pharmacology.

💼PROFESSIONAL ENDEAVORS:

Prof. Qiao undertook a post-doctoral research stint at Zhejiang University between 2008 and 2010. This critical period allowed him to deepen his expertise, focus on innovative methodologies, and establish a strong presence in the academic and professional communities. Currently, he serves as a senior leader at the Shanxi Key Laboratory of Innovative Drug for the Treatment of Serious Diseases Basing on Chronic Inflammation, a role that underscores his leadership and research acumen.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR PHARMACOLOGY:

Prof. Qiao’s primary research revolves around the development of innovative drugs targeting chronic inflammation and serious diseases, bridging traditional Chinese medicine with modern therapeutic approaches. His publication record includes more than 20 research articles, showcasing his commitment to advancing medical knowledge and addressing pressing healthcare challenges.

🌟IMPACT AND INFLUENCE:

Prof. Qiao’s work has earned him the prestigious Shanxi Scientific and Technical Award, a testament to the significance of his contributions. His research not only advances theoretical understanding but also translates into practical solutions, making a tangible impact on the field of medicine and drug development.

📖ACADEMIC CITES AND COLLABORATIONS:

With a consistent record of publishing high-quality research articles, Prof. Qiao has garnered citations and recognition from peers in the scientific community. His collaborative efforts extend to multidisciplinary teams, reflecting his ability to integrate diverse perspectives and foster innovation in research.

🚀LEGACY AND FUTURE CONTRIBUTIONS:

Prof. Qiao’s ongoing dedication to his field ensures his legacy as a pioneer in integrating traditional Chinese medicine with modern scientific practices. His future endeavors are likely to focus on enhancing the efficacy of therapeutic interventions and contributing to the global recognition of traditional Chinese medicine in treating complex diseases.

🏆CONCLUSION:

Prof. Yuan-Biao Qiao’s extensive academic qualifications, professional expertise, impactful research, and leadership make him a standout candidate for recognition as a Best Researcher. His ability to bridge traditional and modern approaches to medicine exemplifies a legacy of innovation and excellence, ensuring his continued influence in shaping the future of healthcare and science.

TOP NOTABLE PUBLICATIONS

Nrf2/NRF1 signaling activation and crosstalk amplify mitochondrial biogenesis in the treatment of triptolide-induced cardiotoxicity using calycosin

Authors: Qi, X.-M., Zhang, W.-Z., Zuo, Y.-Q., Ren, J.-H., Li, Q.-S.

Journal: Cell Biology and Toxicology

Year: 2025

Herb pair of Huangqi-Danggui exerts anti-tumor immunity to breast cancer by upregulating PIK3R1

Authors: Liu, H.-X., Lian, L., Hou, L.-L., Wen, S.-Y., Li, Q.-S.

Journal: Animal Models and Experimental Medicine

Year: 2024

Methionine redox regulation of actin-interacting proteins primarily governs antioxidative signaling and response to the salvianolic acid B treatment in EA.hy926 cells

Authors: Wang, A.-C., Qi, X.-M., Li, Q.-F., Qiao, Y.-B., Li, Q.-S.

Journal: Toxicology and Applied Pharmacology

Year: 2024

Bidirectional crosstalk of the cAMP/ROS-dependent signaling pathways in inflammatory macrophage: An activation of formononetin

Authors: Zhang, L.-F., Zhang, X.-Y., Wang, A.-C., Qiao, Y.-B., Li, Q.-S.

Journal: Toxicology and Applied Pharmacology

Year: 2023

PGC-1α/NRF1-dependent cardiac mitochondrial biogenesis: A druggable pathway of calycosin against triptolide cardiotoxicity

Authors: Qi, X.-M., Qiao, Y.-B., Zhang, Y.-L., Wei, H.-Z., Li, Q.-S.

Journal: Food and Chemical Toxicology

Year: 2023

Improving endothelial cell junction integrity by diphenylmethanone derivatives at oxidative stress: A dual-action directly targeting caveolar caveolin-1

Authors: Zhang, Y.-L., Yuan, H.-X., Sun, J., Qiao, Y.-B., Li, Q.-S.

Journal: Toxicology and Applied Pharmacology

Year: 2022

GSK3β-dependent lysosome biogenesis: An effective pathway to mitigate renal fibrosis with LM49

Authors: Ren, J., Wei, H., Sun, J., Xiao, B., Li, Q.

Journal: Frontiers in Pharmacology

Year: 2022

The protective effects of Mai-Luo-Ning injection against LPS-induced acute lung injury via the TLR4/NF-κB signalling pathway

Authors: Miao, J., Shen, J., Yan, C., Qiao, Y., Li, Q.

Journal: Phytomedicine

Year: 2022

New taraxasterane-type triterpenes from Diaphragma juglandis Fructus

Authors: Tan, J.-Y., Cheng, Y.-G., Li, J.-L., Li, Q.-S., Wang, Y.-L.

Journal: Tetrahedron Letters

Year: 2022

The Chemical Constituents of Diaphragma Juglandis Fructus and Their Inhibitory Effect on α-Glucosidase Activity

Authors: Tan, J., Cheng, Y., Wang, S., Li, Q., Wang, Y.

Journal: Molecules

Year: 2022

Songwen Chen | Arrhythmia | Best Research Article Award

Published on 13/12/202424/02/2025 by Cardiology and Cardiovascular Medicine

Dr. Songwen Chen | Arrhythmia | Best Research Article Award

Dr. Songwen Chen, Shanghai General Hospital, China

Dr. Songwen Chen is an Associate Chief Physician at Shanghai General Hospital and a Master’s Graduate Supervisor at Shanghai Jiao Tong University School of Medicine. He specializes in cardiology and electrophysiology, with extensive experience in catheter ablation for arrhythmias such as atrial fibrillation and ventricular tachycardia. Dr. Chen holds a doctorate in Internal Medicine from Shanghai Jiao Tong University and has published widely on topics including arrhythmia management, skin sympathetic nerve activity, and catheter-based interventions. He has received numerous research grants and plays a key role in educating future cardiologists. His work continues to advance both clinical practice and research in cardiology.

Profile:

Google scholar Profile

🎓 EDUCATION

Dr. Songwen Chen’s educational background is distinguished by his dedication to the field of medicine and cardiology. He earned his Bachelor’s degree in Medicine from Soochow University, followed by a Master’s degree in Internal Medicine from Fudan University’s Zhongshan Hospital. His pursuit of advanced knowledge continued with a Doctorate in Internal Medicine from Shanghai General Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. This strong academic foundation in medical science has provided Dr. Chen with the expertise needed to excel in clinical cardiology and electrophysiology, enabling him to make significant contributions to both research and patient care.

💼 PROFESSIONAL EXPERIENCE:

Dr. Songwen Chen is an Associate Chief Physician in the Department of Cardiology at Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, where he has worked since 2012. In addition to his clinical duties, which include performing electrophysiology studies and catheter ablation for arrhythmias, he also supervises graduate students as a Master’s Graduate Supervisor at Shanghai Jiao Tong University School of Medicine. Dr. Chen has contributed extensively to research, securing several prestigious grants, and publishing numerous studies on topics such as arrhythmia management, electrophysiology, and catheter-based interventions. His professional experience blends clinical practice with significant academic and research achievements.

Research experience

Dr. Songwen Chen has extensive research experience in the field of cardiology, with a focus on electrophysiology and arrhythmia management. His work includes studying catheter ablation techniques for atrial fibrillation, supraventricular tachycardia, and ventricular tachycardia. Dr. Chen has made significant contributions to understanding the role of the inferior vena cava in triggering atrial fibrillation and exploring the relationship between skin sympathetic nerve activity and QT interval variability. He has published in prominent journals such as JACC: Clinical Electrophysiology and Pacing and Clinical Electrophysiology. His research is supported by prestigious grants and has led to innovative advancements in clinical cardiology.

Award And Honors

Dr. Songwen Chen has received several prestigious awards and honors throughout his career, reflecting his exceptional contributions to the field of cardiology. His groundbreaking research has been recognized with grants from prominent organizations such as the National Natural Science Foundation of China and the Shanghai Municipal Commission of Health and Family Planning. Additionally, his innovative work in electrophysiology and catheter ablation for arrhythmias has earned him widespread recognition within the medical community. Dr. Chen’s academic excellence, clinical expertise, and dedication to advancing cardiology make him a highly respected figure, deserving of continued recognition and accolades in his field.

Citations:

Citations – 914
h-index1 – 71
i10-index – 27

Conclusion:

Dr. Songwen Chen stands as a distinguished figure in cardiology, merging clinical expertise with impactful research and education. His dedication to advancing electrophysiology, combined with his leadership at Shanghai General Hospital and Shanghai Jiao Tong University School of Medicine, underscores his commitment to improving cardiovascular health outcomes. Dr. Chen’s work not only elevates patient care but also inspires the next generation of medical professionals, solidifying his legacy in the field of cardiology.

TOP NOTABLE PUBLICATIONS:

Circular RNA Ttc3 regulates cardiac function after myocardial infarction by sponging miR-15b
Authors: L Cai, B Qi, X Wu, S Peng, G Zhou, Y Wei, J Xu, S Chen, S Liu
Journal: Journal of Molecular and Cellular Cardiology
Year: 2019

Triglyceride-glucose index and the risk of heart failure: evidence from two large cohorts and a mendelian randomization analysis
Authors: X Li, JSK Chan, B Guan, S Peng, X Wu, X Lu, J Zhou, JMH Hui, YHA Lee, …
Journal: Cardiovascular diabetology
Year: 2022

Activated CD4+ T cells-derived exosomal miR-142-3p boosts post-ischemic ventricular remodeling by activating myofibroblast
Authors: L Cai, G Chao, W Li, J Zhu, F Li, B Qi, Y Wei, S Chen, G Zhou, X Lu, J Xu, …
Journal: Aging (Albany NY)
Year: 2020

Micro RNA‐30c suppresses the pro‐fibrogenic effects of cardiac fibroblasts induced by TGF‐β1 and prevents atrial fibrosis by targeting TGF β RII
Authors: J Xu, H Wu, S Chen, B Qi, G Zhou, L Cai, L Zhao, Y Wei, S Liu
Journal: Journal of Cellular and Molecular Medicine
Year: 2018

Nav1.8 channels in ganglionated plexi modulate atrial fibrillation inducibility
Authors: B Qi, Y Wei, S Chen, G Zhou, H Li, J Xu, Y Ding, X Lu, L Zhao, F Zhang, …
Journal: Cardiovascular research
Year: 2014

LCZ696 ameliorates oxidative stress and pressure overload‐induced pathological cardiac remodeling by regulating the Sirt3/MnSOD pathway
Authors: S Peng, X Lu, Y Qi, J Li, J Xu, T Yuan, X Wu, Y Ding, W Li, G Zhou, Y Wei, …
Journal: Oxidative Medicine and Cellular Longevity
Year: 2020

Blocking the pulmonary vein to left atrium conduction in addition to the entrance block enhances clinical efficacy in atrial fibrillation ablation
Authors: S Chen, W Meng, D Sheng He, G Chen, F Zhang, Y Yan, Y Zhu-Ge, …
Journal: Pacing and Clinical Electrophysiology
Year: 2012

Potential role of cyanidin 3-glucoside (C3G) in diabetic cardiomyopathy in diabetic rats: an in vivo approach
Authors: W Li, S Chen, G Zhou, H Li, L Zhong, S Liu
Journal: Saudi Journal of Biological Sciences
Year: 2018

Procedural arrhythmia termination and long‐term single‐procedure clinical outcome in patients with non‐paroxysmal atrial fibrillation
Authors: G Zhou, S Chen, G Chen, F Zhang, W Meng, Y Yan, X Lu, Y Wei, S Liu
Journal: Journal of Cardiovascular Electrophysiology
Year: 2013

Age-and sex-related difference in lipid profiles of patients hospitalized with acute myocardial infarction in East China
Authors: Y Wei, B Qi, J Xu, G Zhou, S Chen, P Ouyang, S Liu
Journal: Journal of Clinical Lipidology
Year: 2014

Fulin Liu | Cardiology | Best Researcher Award

Published on 12/12/202412/12/2024 by Cardiology and Cardiovascular Medicine

Prof. Fulin Liu | Cardiology | Best Researcher Award

Prof. Fulin Liu, Affiliated Hospital of Hebei University , China

Prof. Fulin Liu is a distinguished researcher and cardiac surgeon affiliated with the Affiliated Hospital of Hebei University, where he has worked since 1988. He holds a degree from Hebei Medical University and has made significant contributions to cardiovascular health, particularly in myocardial ischemia-reperfusion injury and the therapeutic effects of hydrogen-rich water. Liu has authored numerous high-impact journal articles, with recent work focusing on mitochondrial function, glioma research, and innovative healthcare solutions. His research is widely recognized in leading medical journals, underscoring his global impact and ongoing commitment to advancing medical science and patient care.

Author Profile:

Education:

Prof. Fulin Liu completed his undergraduate education at Hebei Medical University in Shijiazhuang City, Hebei, China. He attended the university from September 1983 to June 1988, where he received a medical degree, which laid the foundation for his career in cardiac surgery and medical research. This academic background has been pivotal in shaping his research focus, particularly in the fields of cardiovascular health, ischemia-reperfusion injury, and the application of hydrogen-rich water in medical treatments. Liu’s educational experiences at Hebei Medical University have significantly influenced his innovative contributions to healthcare and medical science.

Professional Experience:

Prof. Fulin Liu has extensive professional experience in both clinical and research settings. Since 1988, he has been a cardiac surgeon at the Affiliated Hospital of Hebei University, where he has developed expertise in treating cardiovascular conditions, particularly myocardial ischemia-reperfusion injury. In addition to his clinical role, Liu has made significant contributions to medical research, publishing numerous articles on topics such as hydrogen-rich water, mitochondrial function, and glioma. His work bridges the gap between clinical practice and scientific discovery, advancing both patient care and medical knowledge. Liu’s career reflects a dedicated commitment to improving cardiovascular health and innovative therapies.

🌍Research Contributions:

Prof. Fulin Liu’s research contributions focus primarily on cardiovascular health, particularly myocardial ischemia-reperfusion injury and the protective effects of hydrogen-rich water. His studies have revealed critical insights into mitochondrial function and its role in heart disease, with a focus on improving therapeutic strategies. Liu has also made notable contributions to the understanding of gliomas, including the role of circular RNAs and N6-methyladenosine modifications in tumor progression. His work extends to advanced healthcare technologies, such as knowledge graphs and mobile computing in medical applications. Through his numerous published articles, Liu continues to drive innovative research with significant clinical and therapeutic implications.

Award and Honors:

Prof. Fulin Liu has received numerous awards and honors throughout his distinguished career, recognizing his contributions to the field of cardiac surgery and medical research. His groundbreaking work on myocardial ischemia-reperfusion injury, hydrogen-rich water’s therapeutic effects, and his studies on gliomas have earned him widespread acclaim in the scientific community. Liu’s research has been published in top-tier medical journals, and his expertise has garnered international recognition. His dedication to advancing both clinical practices and scientific understanding has established him as a leader in his field, earning him significant accolades and reinforcing his reputation as a pioneering researcher.

Conclusion:

Prof. Fulin Liu’s extensive research and clinical expertise have made him a prominent figure in the field of cardiac surgery and biomedical research. His work on myocardial ischemia-reperfusion injury, hydrogen-rich water, and its therapeutic potential highlights his commitment to advancing cardiovascular medicine. Liu’s contributions to the understanding of molecular mechanisms in diseases like glioma further underscore his multidisciplinary approach to health research. With a remarkable publication record and ongoing involvement in clinical practice, Liu’s impact on both academic and medical communities is profound, establishing him as a leading figure in his field.

Publication Top Notes:

Hydrogen Protects Mitochondrial Function by Increasing the Expression of PGC-1α and Ameliorating Myocardial Ischaemia–Reperfusion Injury
Journal of Cellular and Molecular Medicine, 2024
📖 Citations: 0
[DOI: 10.1111/jcmm.70236]

Spatiotemporal lipidomics reveals key features of brain lipid dynamic changes after cerebral ischemia and reperfusion therapy
Pharmacological Research, 2022
🧠 Citations: 15
[DOI: 10.1016/j.phrs.2022.106482]

Identification and characterization of N6-methyladenosine modification of circRNAs in glioblastoma
Journal of Cellular and Molecular Medicine, 2021
🔬 Citations: 8
[DOI: 10.1111/jcmm.16750]

Multitask Healthcare Management Recommendation System Leveraging Knowledge Graph
Journal of Healthcare Engineering, 2021
💡 Citations: 19
[DOI: 10.1155/2021/1233483]

Medical Knowledge Graph in Chinese Using Deep Semantic Mobile Computation Based on IoT and WoT
Wireless Communications and Mobile Computing, 2021
🌐 Citations: 6
[DOI: 10.1155/2021/5590754]

M6A modification in RNA: Biogenesis, functions and roles in gliomas
Journal of Experimental and Clinical Cancer Research, 2020
🧬 Citations: 117
[DOI: 10.1186/s13046-020-01706-8]

Metabolomics Analysis of the Effect of Hydrogen-Rich Water on Myocardial Ischemia-Reperfusion Injury in Rats
Journal of Bioenergetics and Biomembranes, 2020
💧 Citations: 6
[DOI: 10.1007/s10863-020-09835-7]

Advances in circular RNAs and their role in glioma (Review)
International Journal of Oncology, 2020
🔄 Citations: 26
[DOI: 10.3892/ijo.2020.5049]

New understanding of the damage of SARS-CoV-2 infection outside the respiratory system
Biomedicine and Pharmacotherapy, 2020
🦠 Citations: 222
[DOI: 10.1016/j.biopha.2020.110195]

Pressurizing and Stretching Experiment in Arterialized Veins of Rabbits
Yiyong Shengwu Lixue/Journal of Medical Biomechanics, 2020
🐇 Citations: Not available
[DOI: 10.3969/j.issn.1005-8936.2020.02.006]